Clinical Trials Browser

Phase 1/2 × Skin Neoplasms × Erlotinib Hydrochloride × Clear all

NCT01465815 2014-11-19

Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)

Phase 1/2 Withdrawn

Skin Neoplasms